Impaired Antibody Response to Conjugated Meningococcal Serogroup C Vaccine in Asplenic Patients

European Journal of Clinical Microbiology and Infectious Diseases - Germany
doi 10.1007/s10096-010-1129-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Adoption of Serogroup B Meningococcal Vaccine Recommendations

Pediatrics
Child HealthPediatricsPerinatology
2018English

Impact of Serogroup a Meningococcal Conjugate Vaccine for Africa

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Maintenance of Immune Response Throughout Childhood Following Serogroup C Meningococcal Conjugate Vaccination in Early Childhood

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2012English

Development of a Glycoconjugate Vaccine to Prevent Meningitis in Africa Caused by Meningococcal Serogroup X

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Meningococcal Serogroup B Vaccine Immunogenicity in High-Risk Groups: What Are the Implications?

Pediatrics
Child HealthPediatricsPerinatology
2018English

Potential Benefits of Using a Multicomponent Vaccine for Prevention of Serogroup B Meningococcal Disease

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Outbreak of Serogroup C Meningococcal Disease Among Preschool-Aged Children: Illinois, 1996.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1998English

Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2012English

Modelling Cost Effectiveness of Meningococcal Serogroup C Conjugate Vaccination Campaign in England and Wales

BMJ
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy